Silk based scaffolds with immunomodulatory capacity: anti-inflammatory effects of nicotinic acid.


Journal

Biomaterials science
ISSN: 2047-4849
Titre abrégé: Biomater Sci
Pays: England
ID NLM: 101593571

Informations de publication

Date de publication:
17 Dec 2019
Historique:
pubmed: 31 10 2019
medline: 15 4 2020
entrez: 31 10 2019
Statut: ppublish

Résumé

Implantation of temporary and permanent biomaterials in the body leads to a foreign body reaction (FBR), which may adversely affect tissue repair processes and functional integration of the biomaterial. However, modulation of the inflammatory response towards biomaterials can potentially enable a favorable healing response associated with functional tissue formation and tissue regeneration. In this work, incorporation of nicotinic acid in 3D silk scaffolds is explored as an immunomodulatory strategy for implantable biomaterials. Silk scaffolds were fabricated from dissolved Bombyx mori silk fibers by freeze-drying, resulting in silk scaffolds with high porosity (>94%), well-connected macropores, a high swelling degree (>550%) and resistance to in vitro degradation. Furthermore, drug-loaded scaffolds displayed a sustained drug release and excellent cytocompatibility could be observed with osteoblast-like MG63 cells. Cultivating M1-like macrophages on the scaffolds revealed that scaffolds loaded with nicotinic acid suppress gene expression of pro-inflammatory markers TNF-α, CXCL10 and CD197 as well as secretion of TNF-α in a concentration dependant manner. Hence, this study provides insights into the possible application of nicotinic acid in tissue engineering to control inflammatory responses towards biomaterials and potentially help minimizing FBR.

Identifiants

pubmed: 31663545
doi: 10.1039/c9bm00814d
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Arthropod Proteins 0
Biocompatible Materials 0
Cytokines 0
Delayed-Action Preparations 0
Silk 0
Niacin 2679MF687A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

148-162

Commentaires et corrections

Type : ErratumIn

Auteurs

Abdollah Zakeri Siavashani (A)

Empa, Swiss Federal Laboratories for Materials Science and Technology, Biointerfaces, St.Gallen, Switzerland. markus.rottmar@empa.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH